<bold> COMBINATION OF TUMOR TREATING FIELDS </bold>(TTFIELDS) WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS - A BI-CENTRIC ANALYSIS

被引：0
|
作者：
Lazaridis, Lazaros [1 ]
Schaefer, Niklas [2 ]
Schmidt, Teresa [3 ]
Weller, Johannes [2 ]
Tzaridis, Theophilos-Dimitrios [2 ]
Scheffler, Bjoern [4 ]
Pierscianek, Daniela [5 ]
Kleinschnitz, Christoph [6 ]
Stuschke, Martin [7 ]
Sure, Ulrich [5 ]
Herrlinger, Ulrich [2 ]
Kebir, Sied [1 ]
Glas, Martin [3 ]
机构：
[1] Univ Hosp Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany
[2] Univ Bonn, Div Clin Neurooncol, Dept Neurol, Med Ctr, Bonn, Germany
[3] Univ Duisburg Essen, Univ Hosp Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany
[4] Partner Site Univ Hosp Essen, German Canc Consortium DKTK, West German Canc Ctr WTZ, DKFZ,Div Translat Neurooncol, Essen, Germany
[5] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurosurg, Essen, Germany
[6] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany
[7] Univ Duisburg Essen, Univ Hosp Essen, Dept Radiotherapy, Essen, Germany
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RARE-39
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [31] Baseline tumor genomic and gut microbiota association with clinical outcomes in newly diagnosed glioblastoma (GBM) treated with atezolizumab in combination with temozolomide (TMZ) and radiation.
    Weathers, Shiao-Pei S.
    Zhu, Haifeng
    Knafl, Mark
    Damania, Ashish
    Kamiya-Matsuoka, Carlos
    Harrison, Rebecca A.
    Lyons, Larry
    Yun, Cindy
    Darbonne, Walter C.
    Loghin, Monica
    Penas-Prado, Marta
    Majd, Nazanin
    Yung, W. K. Alfred
    O'Brien, Barbara Jane
    Wistuba, Ignacio Ivan
    Futreal, Andrew
    Wargo, Jennifer Ann
    Ajami, Nadim J.
    Woodman, Scott Eric
    De Groot, John Frederick
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis
    Matthew T. Ballo
    Patrick Conlon
    Gitit Lavy-Shahaf
    Adrian Kinzel
    Josef Vymazal
    Aaron M. Rulseh
    Journal of Neuro-Oncology, 2023, 164 : 1 - 9
  • [33] Tumor Treating Fields (TTFields) for Newly Diagnosed Glioblastoma in the Real World: A Systematic Review and Survival Meta-Analysis
    Ballo, M. T.
    Conlon, P.
    Lavy-Shahaf, G.
    Urman, N.
    Kinzel, A.
    Vymazal, J.
    Rulseh, A. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E85 - E85
  • [34] Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis
    Ballo, Matthew T. T.
    Conlon, Patrick
    Lavy-Shahaf, Gitit
    Kinzel, Adrian
    Vymazal, Josef
    Rulseh, Aaron M. M.
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (1) : 1 - 9
  • [35] Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma
    Miller, Ryan
    Song, Andrew
    Ali, Ayesha
    Niazi, Muneeb
    Bar-Ad, Voichita
    Martinez, Nina
    Glass, Jon
    Alnahhas, Iyad
    Andrews, David
    Judy, Kevin
    Evans, James
    Farrell, Christopher
    Werner-Wasik, Maria
    Chervoneva, Inna
    Ly, Michele
    Palmer, Joshua
    Liu, Haisong
    Shi, Wenyin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] PHASE I/II STUDY TO EVALUATE THE SAFETY AND CLINICAL EFFICACY OF ATEZOLIZUMAB (ATEZO) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Weathers, Shiao-Pei
    Kamiya-Matsuoka, Carlos
    Harrison, Rebecca
    Liu, Diane
    Sanqui, Edmund
    Dervin, Shannon
    Yun, Cindy
    Loghin, Monica
    Penas-Prado, Marta
    Majd, Nazanin
    Yung, W. K. Alfred
    O'Brien, Barbara
    de Groot, John
    NEURO-ONCOLOGY, 2020, 22 : 35 - 35
  • [37] Phase 3 TRIDENT study (EF-32): Tumor treating fields (TTFields; 200 kHz) concomitant with chemoradiation, and maintenance TTFields therapy/temozolomide in newly diagnosed glioblastoma
    Shi, Wenyin
    Roberge, David
    Kleinberg, Lawrence
    Jeyapalan, Suriya A.
    Goldlust, Samuel Aaron
    Nagpal, Seema
    Lustgarten, Leonardo
    Combs, Stephanie E.
    Nishikawa, Ryo
    Reardon, David A.
    Grossman, Rachel
    Glas, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] THE EFFECT OF TIMING OF RADIOTHERAPY (RT) IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) RECEIVING TEMOZOLOMIDE (TMZ): AN ANALYSIS BASED ON THE UCSF EXPERIENCE
    Han, S. J.
    Rutledge, W. C.
    Molinaro, A. M.
    Chang, S.
    Clarke, J. L.
    Prados, M. D.
    Berger, M. S.
    Butowski, N. A.
    NEURO-ONCOLOGY, 2014, 16
  • [39] THE EFFECT OF DELAYING RADIOTHERAPY (RT) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) RECEIVING TEMOZOLOMIDE (TMZ): A SECONDARY ANALYSIS BASED ON THE UCSF EXPERIENCE
    Butowski, Nicholas A.
    Polley, Mei-Yin C.
    Lamborn, Kathleen L.
    Chang, Susan
    Prados, Michael
    Clarke, Jennifer L.
    Huang, Kim
    Sneed, Patricia
    NEURO-ONCOLOGY, 2009, 11 (05) : 665 - 665
  • [40] Safety and efficacy of tumor treating fields (TTFields) prior and concomitant to radiotherapy in patients with newly diagnosed glioblastoma: Results from PriCoTTF
    Kebir, Seid
    Lazaridis, Lazaros
    Schmidt, Teresa
    Oster, Christoph
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca L.
    Krex, Dietmar
    Sure, Ulrich
    Scheffler, Bjoern
    Kleinschnitz, Christoph
    Ttgen, Christoph Po Spacing Diaeresis
    Stuschke, Martin
    Glas, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345